axcelis technologies - ACLS
ACLS
Close Chg Chg %
50.96 -6.17 -12.11%
Closed Market
44.79
-6.17 (12.11%)
Volume: 896.72K
Last Updated:
Apr 3, 2025, 4:00 PM EDT
Company Overview: axcelis technologies - ACLS
ACLS Key Data
Open $48.54 | Day Range 44.79 - 48.98 |
52 Week Range 44.79 - 158.61 | Market Cap $1.64B |
Shares Outstanding 32.15M | Public Float 31.63M |
Beta 1.58 | Rev. Per Employee N/A |
P/E Ratio 8.29 | EPS $6.17 |
Yield 0.00% | Dividend N/A |
EX-DIVIDEND DATE | SHORT INTEREST N/A |
AVERAGE VOLUME 646.20K |
ACLS Performance
1 Week | -9.90% | ||
1 Month | -26.13% | ||
3 Months | -37.76% | ||
1 Year | -57.44% | ||
5 Years | 166.29% |
ACLS Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
9
Full Ratings ➔
About axcelis technologies - ACLS
Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. Its ion implantation systems product line includes high and medium current, and energy implanters. It also offers post-sales equipment service and support, such as spare parts, equipment upgrades, used equipment, maintenance services, and customer training. The company was founded in 1978 and is headquartered in Beverly, MA.
ACLS At a Glance
Axcelis Technologies, Inc.
108 Cherry Hill Drive
Beverly, Massachusetts 01915-1088
Phone | 1-978-787-4000 | Revenue | 1.02B | |
Industry | Industrial Machinery | Net Income | 200.99M | |
Sector | Producer Manufacturing | Employees | 1,524 | |
Fiscal Year-end | 12 / 2025 | |||
View SEC Filings |
ACLS Valuation
P/E Current | 8.292 |
P/E Ratio (with extraordinary items) | N/A |
P/E Ratio (without extraordinary items) | 11.369 |
Price to Sales Ratio | 2.245 |
Price to Book Ratio | 2.233 |
Price to Cash Flow Ratio | 16.227 |
Enterprise Value to EBITDA | 7.887 |
Enterprise Value to Sales | 1.756 |
Total Debt to Enterprise Value | 0.041 |
ACLS Efficiency
Revenue/Employee | 667,890.42 |
Income Per Employee | 131,884.514 |
Receivables Turnover | 5.01 |
Total Asset Turnover | 0.774 |
ACLS Liquidity
Current Ratio | 5.414 |
Quick Ratio | 4.054 |
Cash Ratio | 2.753 |
ACLS Profitability
Gross Margin | 44.667 |
Operating Margin | 20.709 |
Pretax Margin | 22.623 |
Net Margin | 19.746 |
Return on Assets | 15.28 |
Return on Equity | 21.409 |
Return on Total Capital | 18.503 |
Return on Invested Capital | 19.952 |
ACLS Capital Structure
Total Debt to Total Equity | 7.254 |
Total Debt to Total Capital | 6.763 |
Total Debt to Total Assets | 5.447 |
Long-Term Debt to Equity | 6.68 |
Long-Term Debt to Total Capital | 6.228 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Axcelis Technologies - ACLS
Collapse All in section
All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
---|---|---|---|---|---|
Sales/Revenue
| 662.43M | 920.00M | 1.13B | 1.02B | |
Sales Growth
| +39.59% | +38.88% | +22.89% | -9.97% | |
Cost of Goods Sold (COGS) incl D&A
| 372.23M | 518.21M | 639.30M | 563.21M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 10.82M | 11.61M | 13.07M | 15.81M | |
Depreciation
| 10.82M | 11.61M | 13.07M | 15.81M | |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| +36.71% | +39.22% | +23.37% | -11.90% | |
Gross Income
| 290.20M | 401.79M | 491.30M | 454.65M | |
Gross Income Growth
| +43.46% | +38.45% | +22.28% | -7.46% | |
Gross Profit Margin
| +43.81% | +43.67% | +43.45% | +44.67% |
2021 | 2022 | 2023 | 2024 | 5-year trend | |
---|---|---|---|---|---|
SG&A Expense
| 159.12M | 189.43M | 225.51M | 243.86M | |
Research & Development
| 65.43M | 78.36M | 96.91M | 105.50M | |
Other SG&A
| 93.69M | 111.07M | 128.60M | 138.36M | |
SGA Growth
| +13.22% | +19.05% | +19.05% | +8.14% | |
Other Operating Expense
| - | - | - | 3.75M | - |
Unusual Expense
| - | - | - | - | - |
EBIT after Unusual Expense
| 127.33M | 212.36M | 265.80M | 210.79M | |
Non Operating Income/Expense
| (2.06M) | (1.90M) | 18.15M | 24.94M | |
Non-Operating Interest Income
| 209.00K | 4.55M | 18.20M | 24.40M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 4.83M | 5.58M | 5.35M | 5.46M | |
Interest Expense Growth
| -7.22% | +15.33% | -4.11% | +2.15% | |
Gross Interest Expense
| 4.83M | 5.58M | 5.35M | 5.46M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 120.43M | 204.88M | 278.60M | 230.27M | |
Pretax Income Growth
| +115.49% | +70.13% | +35.98% | -17.35% | |
Pretax Margin
| +18.18% | +22.27% | +24.64% | +22.62% | |
Income Tax
| 21.78M | 21.81M | 32.34M | 29.28M | |
Income Tax - Current - Domestic
| 82.00K | 10.15M | 48.86M | 40.99M | |
Income Tax - Current - Foreign
| 1.44M | 3.12M | 3.50M | 3.89M | |
Income Tax - Deferred - Domestic
| 20.93M | 8.99M | (18.97M) | (13.55M) | |
Income Tax - Deferred - Foreign
| (670.00K) | (459.00K) | (1.05M) | (2.04M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 98.65M | 183.08M | 246.26M | 200.99M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 98.65M | 183.08M | 246.26M | 200.99M | |
Net Income Growth
| +97.37% | +85.58% | +34.51% | -18.38% | |
Net Margin Growth
| +14.89% | +19.90% | +21.78% | +19.75% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 98.65M | 183.08M | 246.26M | 200.99M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 98.65M | 183.08M | 246.26M | 200.99M | |
EPS (Basic)
| 2.94 | 5.5406 | 7.5176 | 6.1745 | |
EPS (Basic) Growth
| +95.62% | +88.46% | +35.68% | -17.87% | |
Basic Shares Outstanding
| 33.55M | 33.04M | 32.76M | 32.55M | |
EPS (Diluted)
| 2.8788 | 5.4582 | 7.4254 | 6.1458 | |
EPS (Diluted) Growth
| +96.56% | +89.60% | +36.04% | -17.23% | |
Diluted Shares Outstanding
| 34.27M | 33.54M | 33.16M | 32.70M | |
EBITDA
| 138.14M | 223.97M | 278.86M | 226.60M | |
EBITDA Growth
| +103.21% | +62.13% | +24.51% | -18.74% | |
EBITDA Margin
| +20.85% | +24.34% | +24.67% | +22.26% |
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 104.00 | |
Number of Ratings | 9 | Current Quarters Estimate | 0.495 | |
FY Report Date | 06 / 2025 | Current Year's Estimate | 2.324 | |
Last Quarter’s Earnings | 0.38 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 6.15 | Next Fiscal Year Estimate | 3.757 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 8 | 8 | 8 | 6 |
Mean Estimate | 0.50 | 0.65 | 2.32 | 3.76 |
High Estimates | 0.61 | 0.77 | 2.71 | 5.00 |
Low Estimate | 0.43 | 0.47 | 1.82 | 2.16 |
Coefficient of Variance | 12.73 | 16.68 | 12.74 | 25.87 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 4 | 4 | 5 |
OVERWEIGHT | 0 | 0 | 0 |
HOLD | 5 | 5 | 4 |
UNDERWEIGHT | 0 | 0 | 0 |
SELL | 0 | 0 | 0 |
MEAN | Overweight | Overweight | Overweight |
SEC Filings for Axcelis Technologies - ACLS
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Axcelis Technologies - ACLS
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Jun 25, 2024 | Douglas A. Lawson EVP, CORPORATE MKTG & STRATEGY | 15,808 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $136.02 per share | 2,150,204.16 |
Jun 19, 2024 | Gerald M Blumenstock EVP, Engineering | 9,572 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $138.02 per share | 1,321,127.44 |
Jun 19, 2024 | Greg Redinbo EVP MARKETING AND APPLICATIONS | 21,914 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $138.02 per share | 3,024,570.28 |
Jun 6, 2024 | Lynnette C. Fallon EXECUTIVE VP, HR/LEGAL AND GEN | 30,406 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $111.29 per share | 3,383,883.74 |
Jun 6, 2024 | Russell J. Low PRESIDENT AND CEO; Director | 81,566 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $111.29 per share | 9,077,480.14 |
May 29, 2024 | Christopher Tatnall EVP Global Customer Operations | 7,776 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 | 0.00 |
May 21, 2024 | John T. Kurtzweil Director | 33,146 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $114.42 per share | 3,792,565.32 |
May 17, 2024 | Thomas St. Dennis Director | 13,569 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Christopher Tatnall EVP Global Customer Operations | 13,371 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $112.94 per share | 1,510,120.74 |
May 17, 2024 | Christopher Tatnall EVP Global Customer Operations | 13,474 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Jeanne Quirk Director | 8,162 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Dipti Vachani Director | 9,063 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Necip Sayiner Director | 3,672 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Tzu Yin Chiu Director | 6,817 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Jorge Luis Titinger Director | 11,977 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Gregory B. Graves Director | 3,672 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 16, 2024 | James G. Coogan EVP AND CFO | 15,487 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 16, 2024 | James G. Coogan EVP AND CFO | 10,739 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 16, 2024 | Gerald M Blumenstock EVP, Engineering | 9,880 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 14, 2024 | Mary G. Puma EXECUTIVE CHAIRPERSON; Director | 231,976 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $113.04 per share | 26,222,567.04 |